Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours.
about
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapyClinical trials and progress with paclitaxel in ovarian cancer2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancerSelf-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
P2860
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@ast
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@en
type
label
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@ast
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@en
prefLabel
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@ast
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@en
P2093
P2860
P356
P1476
Phase I/II study of DHA-paclit ...... anced malignant solid tumours.
@en
P2093
Greystoke A
O'Donnell A
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602196
P407
P577
2004-11-01T00:00:00Z
P5875
P6179
1011727829